Search results
Limited evidence citing small pilot or proof of concept studies suggest that the synthetic medical cannabis extract dronabinol may improve respiratory stability and provide benefit to treat OSA.
15 kwi 2018 · The diagnosis and effective treatment of obstructive sleep apnea (OSA) in adults is an urgent health priority. Positive airway pressure (PAP) therapy remains the most effective treatment for OSA, a...
Recently, the medical cannabis citizens' review panel at the Minnesota Department of Health (MDH) added obstructive sleep apnea (OSA) to the list of qualifying conditions for medical cannabis, making Minnesota the first state to approve the use of cannabis for OSA.
18 maj 2022 · It is possible that short-term cannabinoid therapy could be beneficial for reducing anxiety and improving acceptance and adherence to continuous positive airway pressure therapy for treatment of OSA, and it may also have the potential to suppress treatment emergent central sleep apnea.
Positive airway pressure (PAP) therapy remains the most effective treatment for OSA, although other treatment options continue to be explored. Limited evidence citing small pilot or proof of concept studies suggest that the synthetic medical cannabis extract dronabinol may improve respiratory stability and provide benefit to treat OSA.
5 maj 2018 · The results of the recent pharmacotherapy of apnea by cannabimimetic enhancement (PACE) trial that studied the effects of dronabinol (a cannabinoid) on the effects of obstructive sleep apnea look promising. 1 In light of this study and the upcoming legalization of marijuana in Canada, could the authors of the recent CMAJ review 2 on the ...
2 kwi 2024 · For example, synthetic forms of THC have shown potential for treating obstructive sleep apnea, reducing PTSD-related nightmares, and improving sleep for people living with chronic pain. CBD, on the other hand, may reduce symptoms of REM sleep behavior disorder and excessive daytime sleepiness.
